Georgia's Online Cancer Information Center

Find A Clinical Trial

A Randomized Phase 2 Study of Cabozantinib (XL184) in Combination With Abiraterone in Chemotherapy Naïve Subjects With Bone-Metastatic Castration-Resistant Prostate Cancer

Status
Active
Cancer Type
Prostate Cancer
Trial Phase
Phase II
Eligibility
18 and older, Male
Study Type
Treatment
NCD ID
NCT01995058
Protocol IDs
XL184-210 (primary)
Study Sponsor
Exelixis
NCI Full Details
Georgia CORE

 

Hearts and Minds Dedicated to Improving Cancer Care

Georgia CORE is a public-private partnership that creates collaboration among the state’s cancer organizations and institutions to connect more Georgians to quality, personalized cancer care. We welcome you to this one-of-a-kind online information center for all things related to cancer and survivorship care in Georgia.